4 citations
,
April 2020 in “medRxiv (Cold Spring Harbor Laboratory)” This case-control study from Lombardy, Italy, observed that men over 55 taking 5-alpha reductase inhibitors for benign prostatic hyperplasia were hospitalized for COVID-19 at a lower rate than age-matched controls, suggesting potential protective effects against severe disease.
1 citations
,
November 2021 in “World Family Medicine Journal /Middle East Journal of Family Medicine” This study found that COVID-19 had more severe outcomes in asthmatic patients, with increased ICU admissions and oxygen needs, particularly when asthma control was poor.
January 2024 in “Technology in Cancer Research & Treatment” This study found that anti-angiogenic drugs did not significantly affect COVID-19 severity, ICU admission, or mortality in patients with non-small cell lung cancer.
January 2021 in “Journal of the European Academy of Dermatology and Venereology” PrEP doesn't increase STI risk in high-risk men, anti-androgen drugs may lower ICU admission for male COVID-19 patients, a 3-point injection is better for crow's feet, and the 'Geriatric-8' tool could help assess frailty in older skin cancer patients.
18 citations
,
September 2020 in “BMC Public Health” This study found that non-Kuwaiti COVID-19 patients in Kuwait had higher odds of death, ICU admission, ARDS, and pneumonia compared to Kuwaiti patients.